Human Papillomavirus (HPV) 16 High-Risk Detection And Genotyping Kit (PCR-Fluorescence)

A diagnostic test kit for the detection of human papillomavirus types 16 and 18 using PCR with fluorescence methodology. This kit is used to identify HPV infection status in clinical specimens.

In vitro qualitative detection kit for 18 types of high-risk HPV using fluorescence PCR technology. Suitable for urine, cervical swab, and vaginal swab samples with HPV 16/18 typing capability. CE and TFDA approved for clinical diagnostic use.

This kit is suitable for in vitro qualitative detection of 18 types of human papillomavirus (HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) specific nucleic acid fragments in human urine samples, female cervical swab samples, female vaginal swab samples, and HPV 16/18 typing.

This kit is suitable for in vitro qualitative detection of 17 types of human papillomavirus (HPV 6, 11, 16, 18, 31, 33, 35, 39, 44, 45, 51, 52, 56, 58, 59, 66, 68) specific nucleic acid fragments in urine samples, female cervical swab samples, and female vaginal swab samples, as well as HPV 16/18/6/11/44 typing detection.

A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.

This kit is suitable for in vitro qualitative detection of 28 types of human papillomavirus (HPV 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acids in clinical urine samples, female cervical swab samples, and female vaginal swab samples, as well as HPV 16/18/45 typing detection, while providing aid in the diagnosis and treatment of HPV infection.

Fluorescence PCR-based detection kit for Human Papillomavirus (HPV) identification in clinical specimens. Enables rapid, sensitive HPV genotyping for cervical cancer screening and risk stratification in diagnostic laboratories. 510(k) cleared device with fluorescence-based detection methodology.

HPV 15 genotype detection kit using fluorescence PCR melting curve analysis for identifying human papillomavirus types in clinical specimens. Enables rapid, simultaneous detection and differentiation of multiple HPV genotypes relevant to cervical cancer screening and risk stratification.

In vitro qualitative detection kit for 15 high-risk HPV E6/E7 mRNA subtypes in cervical exfoliated cell samples. Detects HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 for cervical cancer and precancerous lesion risk assessment. NMPA Class III medical device registered.

Fluorescence PCR-based detection kit for human immunodeficiency virus (HIV) identification in clinical specimens. Provides sensitive and specific HIV diagnosis through real-time PCR technology. Intended for laboratory use in diagnostic settings to aid in HIV screening and confirmation.

A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.

PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.